1 Study Coverage
1.1 Plasma Fractionation and Blood Product Product Introduction
1.2 Market by Type
1.2.1 Global Plasma Fractionation and Blood Product Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Coagulation Factor
1.2.3 Immune Globulin
1.2.4 Albumin
1.2.5 Other
1.3 Market by Application
1.3.1 Global Plasma Fractionation and Blood Product Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Immunology
1.3.3 Hematology
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Plasma Fractionation and Blood Product Sales Estimates and Forecasts 2017-2028
2.2 Global Plasma Fractionation and Blood Product Revenue Estimates and Forecasts 2017-2028
2.3 Global Plasma Fractionation and Blood Product Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Plasma Fractionation and Blood Product Sales by Region
2.4.1 Global Plasma Fractionation and Blood Product Sales by Region (2017-2022)
2.4.2 Global Sales Plasma Fractionation and Blood Product by Region (2023-2028)
2.5 Global Plasma Fractionation and Blood Product Revenue by Region
2.5.1 Global Plasma Fractionation and Blood Product Revenue by Region (2017-2022)
2.5.2 Global Plasma Fractionation and Blood Product Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Plasma Fractionation and Blood Product Sales by Manufacturers
3.1.1 Global Top Plasma Fractionation and Blood Product Manufacturers by Sales (2017-2022)
3.1.2 Global Plasma Fractionation and Blood Product Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Plasma Fractionation and Blood Product in 2021
3.2 Global Plasma Fractionation and Blood Product Revenue by Manufacturers
3.2.1 Global Plasma Fractionation and Blood Product Revenue by Manufacturers (2017-2022)
3.2.2 Global Plasma Fractionation and Blood Product Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Plasma Fractionation and Blood Product Revenue in 2021
3.3 Global Plasma Fractionation and Blood Product Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Plasma Fractionation and Blood Product Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Plasma Fractionation and Blood Product Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Plasma Fractionation and Blood Product Sales by Type
4.1.1 Global Plasma Fractionation and Blood Product Historical Sales by Type (2017-2022)
4.1.2 Global Plasma Fractionation and Blood Product Forecasted Sales by Type (2023-2028)
4.1.3 Global Plasma Fractionation and Blood Product Sales Market Share by Type (2017-2028)
4.2 Global Plasma Fractionation and Blood Product Revenue by Type
4.2.1 Global Plasma Fractionation and Blood Product Historical Revenue by Type (2017-2022)
4.2.2 Global Plasma Fractionation and Blood Product Forecasted Revenue by Type (2023-2028)
4.2.3 Global Plasma Fractionation and Blood Product Revenue Market Share by Type (2017-2028)
4.3 Global Plasma Fractionation and Blood Product Price by Type
4.3.1 Global Plasma Fractionation and Blood Product Price by Type (2017-2022)
4.3.2 Global Plasma Fractionation and Blood Product Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Plasma Fractionation and Blood Product Sales by Application
5.1.1 Global Plasma Fractionation and Blood Product Historical Sales by Application (2017-2022)
5.1.2 Global Plasma Fractionation and Blood Product Forecasted Sales by Application (2023-2028)
5.1.3 Global Plasma Fractionation and Blood Product Sales Market Share by Application (2017-2028)
5.2 Global Plasma Fractionation and Blood Product Revenue by Application
5.2.1 Global Plasma Fractionation and Blood Product Historical Revenue by Application (2017-2022)
5.2.2 Global Plasma Fractionation and Blood Product Forecasted Revenue by Application (2023-2028)
5.2.3 Global Plasma Fractionation and Blood Product Revenue Market Share by Application (2017-2028)
5.3 Global Plasma Fractionation and Blood Product Price by Application
5.3.1 Global Plasma Fractionation and Blood Product Price by Application (2017-2022)
5.3.2 Global Plasma Fractionation and Blood Product Price Forecast by Application (2023-2028)
6 North America
6.1 North America Plasma Fractionation and Blood Product Market Size by Type
6.1.1 North America Plasma Fractionation and Blood Product Sales by Type (2017-2028)
6.1.2 North America Plasma Fractionation and Blood Product Revenue by Type (2017-2028)
6.2 North America Plasma Fractionation and Blood Product Market Size by Application
6.2.1 North America Plasma Fractionation and Blood Product Sales by Application (2017-2028)
6.2.2 North America Plasma Fractionation and Blood Product Revenue by Application (2017-2028)
6.3 North America Plasma Fractionation and Blood Product Market Size by Country
6.3.1 North America Plasma Fractionation and Blood Product Sales by Country (2017-2028)
6.3.2 North America Plasma Fractionation and Blood Product Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Plasma Fractionation and Blood Product Market Size by Type
7.1.1 Europe Plasma Fractionation and Blood Product Sales by Type (2017-2028)
7.1.2 Europe Plasma Fractionation and Blood Product Revenue by Type (2017-2028)
7.2 Europe Plasma Fractionation and Blood Product Market Size by Application
7.2.1 Europe Plasma Fractionation and Blood Product Sales by Application (2017-2028)
7.2.2 Europe Plasma Fractionation and Blood Product Revenue by Application (2017-2028)
7.3 Europe Plasma Fractionation and Blood Product Market Size by Country
7.3.1 Europe Plasma Fractionation and Blood Product Sales by Country (2017-2028)
7.3.2 Europe Plasma Fractionation and Blood Product Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Plasma Fractionation and Blood Product Market Size by Type
8.1.1 Asia Pacific Plasma Fractionation and Blood Product Sales by Type (2017-2028)
8.1.2 Asia Pacific Plasma Fractionation and Blood Product Revenue by Type (2017-2028)
8.2 Asia Pacific Plasma Fractionation and Blood Product Market Size by Application
8.2.1 Asia Pacific Plasma Fractionation and Blood Product Sales by Application (2017-2028)
8.2.2 Asia Pacific Plasma Fractionation and Blood Product Revenue by Application (2017-2028)
8.3 Asia Pacific Plasma Fractionation and Blood Product Market Size by Region
8.3.1 Asia Pacific Plasma Fractionation and Blood Product Sales by Region (2017-2028)
8.3.2 Asia Pacific Plasma Fractionation and Blood Product Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Plasma Fractionation and Blood Product Market Size by Type
9.1.1 Latin America Plasma Fractionation and Blood Product Sales by Type (2017-2028)
9.1.2 Latin America Plasma Fractionation and Blood Product Revenue by Type (2017-2028)
9.2 Latin America Plasma Fractionation and Blood Product Market Size by Application
9.2.1 Latin America Plasma Fractionation and Blood Product Sales by Application (2017-2028)
9.2.2 Latin America Plasma Fractionation and Blood Product Revenue by Application (2017-2028)
9.3 Latin America Plasma Fractionation and Blood Product Market Size by Country
9.3.1 Latin America Plasma Fractionation and Blood Product Sales by Country (2017-2028)
9.3.2 Latin America Plasma Fractionation and Blood Product Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Plasma Fractionation and Blood Product Market Size by Type
10.1.1 Middle East and Africa Plasma Fractionation and Blood Product Sales by Type (2017-2028)
10.1.2 Middle East and Africa Plasma Fractionation and Blood Product Revenue by Type (2017-2028)
10.2 Middle East and Africa Plasma Fractionation and Blood Product Market Size by Application
10.2.1 Middle East and Africa Plasma Fractionation and Blood Product Sales by Application (2017-2028)
10.2.2 Middle East and Africa Plasma Fractionation and Blood Product Revenue by Application (2017-2028)
10.3 Middle East and Africa Plasma Fractionation and Blood Product Market Size by Country
10.3.1 Middle East and Africa Plasma Fractionation and Blood Product Sales by Country (2017-2028)
10.3.2 Middle East and Africa Plasma Fractionation and Blood Product Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Takeda
11.1.1 Takeda Corporation Information
11.1.2 Takeda Overview
11.1.3 Takeda Plasma Fractionation and Blood Product Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Takeda Plasma Fractionation and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Takeda Recent Developments
11.2 CSL
11.2.1 CSL Corporation Information
11.2.2 CSL Overview
11.2.3 CSL Plasma Fractionation and Blood Product Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 CSL Plasma Fractionation and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 CSL Recent Developments
11.3 Grifols
11.3.1 Grifols Corporation Information
11.3.2 Grifols Overview
11.3.3 Grifols Plasma Fractionation and Blood Product Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Grifols Plasma Fractionation and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Grifols Recent Developments
11.4 Octapharma
11.4.1 Octapharma Corporation Information
11.4.2 Octapharma Overview
11.4.3 Octapharma Plasma Fractionation and Blood Product Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Octapharma Plasma Fractionation and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Octapharma Recent Developments
11.5 Kedrion
11.5.1 Kedrion Corporation Information
11.5.2 Kedrion Overview
11.5.3 Kedrion Plasma Fractionation and Blood Product Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Kedrion Plasma Fractionation and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Kedrion Recent Developments
11.6 LFB Group
11.6.1 LFB Group Corporation Information
11.6.2 LFB Group Overview
11.6.3 LFB Group Plasma Fractionation and Blood Product Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 LFB Group Plasma Fractionation and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 LFB Group Recent Developments
11.7 Biotest
11.7.1 Biotest Corporation Information
11.7.2 Biotest Overview
11.7.3 Biotest Plasma Fractionation and Blood Product Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Biotest Plasma Fractionation and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Biotest Recent Developments
11.8 BPL
11.8.1 BPL Corporation Information
11.8.2 BPL Overview
11.8.3 BPL Plasma Fractionation and Blood Product Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 BPL Plasma Fractionation and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 BPL Recent Developments
11.9 RAAS
11.9.1 RAAS Corporation Information
11.9.2 RAAS Overview
11.9.3 RAAS Plasma Fractionation and Blood Product Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 RAAS Plasma Fractionation and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 RAAS Recent Developments
11.10 CBPO
11.10.1 CBPO Corporation Information
11.10.2 CBPO Overview
11.10.3 CBPO Plasma Fractionation and Blood Product Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 CBPO Plasma Fractionation and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 CBPO Recent Developments
11.11 Hualan Bio
11.11.1 Hualan Bio Corporation Information
11.11.2 Hualan Bio Overview
11.11.3 Hualan Bio Plasma Fractionation and Blood Product Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Hualan Bio Plasma Fractionation and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Hualan Bio Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Plasma Fractionation and Blood Product Industry Chain Analysis
12.2 Plasma Fractionation and Blood Product Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Plasma Fractionation and Blood Product Production Mode & Process
12.4 Plasma Fractionation and Blood Product Sales and Marketing
12.4.1 Plasma Fractionation and Blood Product Sales Channels
12.4.2 Plasma Fractionation and Blood Product Distributors
12.5 Plasma Fractionation and Blood Product Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Plasma Fractionation and Blood Product Industry Trends
13.2 Plasma Fractionation and Blood Product Market Drivers
13.3 Plasma Fractionation and Blood Product Market Challenges
13.4 Plasma Fractionation and Blood Product Market Restraints
14 Key Findings in The Global Plasma Fractionation and Blood Product Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Plasma Fractionation and Blood Product Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Coagulation Factor
Table 3. Major Manufacturers of Immune Globulin
Table 4. Major Manufacturers of Albumin
Table 5. Major Manufacturers of Other
Table 6. Global Plasma Fractionation and Blood Product Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Plasma Fractionation and Blood Product Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Plasma Fractionation and Blood Product Sales by Region (2017-2022) & (K Units)
Table 9. Global Plasma Fractionation and Blood Product Sales Market Share by Region (2017-2022)
Table 10. Global Plasma Fractionation and Blood Product Sales by Region (2023-2028) & (K Units)
Table 11. Global Plasma Fractionation and Blood Product Sales Market Share by Region (2023-2028)
Table 12. Global Plasma Fractionation and Blood Product Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Plasma Fractionation and Blood Product Revenue Market Share by Region (2017-2022)
Table 14. Global Plasma Fractionation and Blood Product Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global Plasma Fractionation and Blood Product Revenue Market Share by Region (2023-2028)
Table 16. Global Plasma Fractionation and Blood Product Sales by Manufacturers (2017-2022) & (K Units)
Table 17. Global Plasma Fractionation and Blood Product Sales Share by Manufacturers (2017-2022)
Table 18. Global Plasma Fractionation and Blood Product Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global Plasma Fractionation and Blood Product Revenue Share by Manufacturers (2017-2022)
Table 20. Plasma Fractionation and Blood Product Price by Manufacturers (2017-2022) &(US$/Unit)
Table 21. Global Plasma Fractionation and Blood Product Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Plasma Fractionation and Blood Product by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma Fractionation and Blood Product as of 2021)
Table 23. Plasma Fractionation and Blood Product Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Plasma Fractionation and Blood Product Product Offered
Table 25. Date of Manufacturers Enter into Plasma Fractionation and Blood Product Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Plasma Fractionation and Blood Product Sales by Type (2017-2022) & (K Units)
Table 28. Global Plasma Fractionation and Blood Product Sales by Type (2023-2028) & (K Units)
Table 29. Global Plasma Fractionation and Blood Product Sales Share by Type (2017-2022)
Table 30. Global Plasma Fractionation and Blood Product Sales Share by Type (2023-2028)
Table 31. Global Plasma Fractionation and Blood Product Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global Plasma Fractionation and Blood Product Revenue by Type (2023-2028) & (US$ Million)
Table 33. Global Plasma Fractionation and Blood Product Revenue Share by Type (2017-2022)
Table 34. Global Plasma Fractionation and Blood Product Revenue Share by Type (2023-2028)
Table 35. Plasma Fractionation and Blood Product Price by Type (2017-2022) & (US$/Unit)
Table 36. Global Plasma Fractionation and Blood Product Price Forecast by Type (2023-2028) & (US$/Unit)
Table 37. Global Plasma Fractionation and Blood Product Sales by Application (2017-2022) & (K Units)
Table 38. Global Plasma Fractionation and Blood Product Sales by Application (2023-2028) & (K Units)
Table 39. Global Plasma Fractionation and Blood Product Sales Share by Application (2017-2022)
Table 40. Global Plasma Fractionation and Blood Product Sales Share by Application (2023-2028)
Table 41. Global Plasma Fractionation and Blood Product Revenue by Application (2017-2022) & (US$ Million)
Table 42. Global Plasma Fractionation and Blood Product Revenue by Application (2023-2028) & (US$ Million)
Table 43. Global Plasma Fractionation and Blood Product Revenue Share by Application (2017-2022)
Table 44. Global Plasma Fractionation and Blood Product Revenue Share by Application (2023-2028)
Table 45. Plasma Fractionation and Blood Product Price by Application (2017-2022) & (US$/Unit)
Table 46. Global Plasma Fractionation and Blood Product Price Forecast by Application (2023-2028) & (US$/Unit)
Table 47. North America Plasma Fractionation and Blood Product Sales by Type (2017-2022) & (K Units)
Table 48. North America Plasma Fractionation and Blood Product Sales by Type (2023-2028) & (K Units)
Table 49. North America Plasma Fractionation and Blood Product Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America Plasma Fractionation and Blood Product Revenue by Type (2023-2028) & (US$ Million)
Table 51. North America Plasma Fractionation and Blood Product Sales by Application (2017-2022) & (K Units)
Table 52. North America Plasma Fractionation and Blood Product Sales by Application (2023-2028) & (K Units)
Table 53. North America Plasma Fractionation and Blood Product Revenue by Application (2017-2022) & (US$ Million)
Table 54. North America Plasma Fractionation and Blood Product Revenue by Application (2023-2028) & (US$ Million)
Table 55. North America Plasma Fractionation and Blood Product Sales by Country (2017-2022) & (K Units)
Table 56. North America Plasma Fractionation and Blood Product Sales by Country (2023-2028) & (K Units)
Table 57. North America Plasma Fractionation and Blood Product Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America Plasma Fractionation and Blood Product Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe Plasma Fractionation and Blood Product Sales by Type (2017-2022) & (K Units)
Table 60. Europe Plasma Fractionation and Blood Product Sales by Type (2023-2028) & (K Units)
Table 61. Europe Plasma Fractionation and Blood Product Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe Plasma Fractionation and Blood Product Revenue by Type (2023-2028) & (US$ Million)
Table 63. Europe Plasma Fractionation and Blood Product Sales by Application (2017-2022) & (K Units)
Table 64. Europe Plasma Fractionation and Blood Product Sales by Application (2023-2028) & (K Units)
Table 65. Europe Plasma Fractionation and Blood Product Revenue by Application (2017-2022) & (US$ Million)
Table 66. Europe Plasma Fractionation and Blood Product Revenue by Application (2023-2028) & (US$ Million)
Table 67. Europe Plasma Fractionation and Blood Product Sales by Country (2017-2022) & (K Units)
Table 68. Europe Plasma Fractionation and Blood Product Sales by Country (2023-2028) & (K Units)
Table 69. Europe Plasma Fractionation and Blood Product Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe Plasma Fractionation and Blood Product Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific Plasma Fractionation and Blood Product Sales by Type (2017-2022) & (K Units)
Table 72. Asia Pacific Plasma Fractionation and Blood Product Sales by Type (2023-2028) & (K Units)
Table 73. Asia Pacific Plasma Fractionation and Blood Product Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific Plasma Fractionation and Blood Product Revenue by Type (2023-2028) & (US$ Million)
Table 75. Asia Pacific Plasma Fractionation and Blood Product Sales by Application (2017-2022) & (K Units)
Table 76. Asia Pacific Plasma Fractionation and Blood Product Sales by Application (2023-2028) & (K Units)
Table 77. Asia Pacific Plasma Fractionation and Blood Product Revenue by Application (2017-2022) & (US$ Million)
Table 78. Asia Pacific Plasma Fractionation and Blood Product Revenue by Application (2023-2028) & (US$ Million)
Table 79. Asia Pacific Plasma Fractionation and Blood Product Sales by Region (2017-2022) & (K Units)
Table 80. Asia Pacific Plasma Fractionation and Blood Product Sales by Region (2023-2028) & (K Units)
Table 81. Asia Pacific Plasma Fractionation and Blood Product Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific Plasma Fractionation and Blood Product Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America Plasma Fractionation and Blood Product Sales by Type (2017-2022) & (K Units)
Table 84. Latin America Plasma Fractionation and Blood Product Sales by Type (2023-2028) & (K Units)
Table 85. Latin America Plasma Fractionation and Blood Product Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America Plasma Fractionation and Blood Product Revenue by Type (2023-2028) & (US$ Million)
Table 87. Latin America Plasma Fractionation and Blood Product Sales by Application (2017-2022) & (K Units)
Table 88. Latin America Plasma Fractionation and Blood Product Sales by Application (2023-2028) & (K Units)
Table 89. Latin America Plasma Fractionation and Blood Product Revenue by Application (2017-2022) & (US$ Million)
Table 90. Latin America Plasma Fractionation and Blood Product Revenue by Application (2023-2028) & (US$ Million)
Table 91. Latin America Plasma Fractionation and Blood Product Sales by Country (2017-2022) & (K Units)
Table 92. Latin America Plasma Fractionation and Blood Product Sales by Country (2023-2028) & (K Units)
Table 93. Latin America Plasma Fractionation and Blood Product Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America Plasma Fractionation and Blood Product Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa Plasma Fractionation and Blood Product Sales by Type (2017-2022) & (K Units)
Table 96. Middle East and Africa Plasma Fractionation and Blood Product Sales by Type (2023-2028) & (K Units)
Table 97. Middle East and Africa Plasma Fractionation and Blood Product Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Plasma Fractionation and Blood Product Revenue by Type (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Plasma Fractionation and Blood Product Sales by Application (2017-2022) & (K Units)
Table 100. Middle East and Africa Plasma Fractionation and Blood Product Sales by Application (2023-2028) & (K Units)
Table 101. Middle East and Africa Plasma Fractionation and Blood Product Revenue by Application (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Plasma Fractionation and Blood Product Revenue by Application (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Plasma Fractionation and Blood Product Sales by Country (2017-2022) & (K Units)
Table 104. Middle East and Africa Plasma Fractionation and Blood Product Sales by Country (2023-2028) & (K Units)
Table 105. Middle East and Africa Plasma Fractionation and Blood Product Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Plasma Fractionation and Blood Product Revenue by Country (2023-2028) & (US$ Million)
Table 107. Takeda Corporation Information
Table 108. Takeda Description and Major Businesses
Table 109. Takeda Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 110. Takeda Plasma Fractionation and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Takeda Recent Developments
Table 112. CSL Corporation Information
Table 113. CSL Description and Major Businesses
Table 114. CSL Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 115. CSL Plasma Fractionation and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. CSL Recent Developments
Table 117. Grifols Corporation Information
Table 118. Grifols Description and Major Businesses
Table 119. Grifols Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 120. Grifols Plasma Fractionation and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Grifols Recent Developments
Table 122. Octapharma Corporation Information
Table 123. Octapharma Description and Major Businesses
Table 124. Octapharma Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 125. Octapharma Plasma Fractionation and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Octapharma Recent Developments
Table 127. Kedrion Corporation Information
Table 128. Kedrion Description and Major Businesses
Table 129. Kedrion Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 130. Kedrion Plasma Fractionation and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Kedrion Recent Developments
Table 132. LFB Group Corporation Information
Table 133. LFB Group Description and Major Businesses
Table 134. LFB Group Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 135. LFB Group Plasma Fractionation and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. LFB Group Recent Developments
Table 137. Biotest Corporation Information
Table 138. Biotest Description and Major Businesses
Table 139. Biotest Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 140. Biotest Plasma Fractionation and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Biotest Recent Developments
Table 142. BPL Corporation Information
Table 143. BPL Description and Major Businesses
Table 144. BPL Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 145. BPL Plasma Fractionation and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. BPL Recent Developments
Table 147. RAAS Corporation Information
Table 148. RAAS Description and Major Businesses
Table 149. RAAS Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 150. RAAS Plasma Fractionation and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. RAAS Recent Developments
Table 152. CBPO Corporation Information
Table 153. CBPO Description and Major Businesses
Table 154. CBPO Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 155. CBPO Plasma Fractionation and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. CBPO Recent Developments
Table 157. Hualan Bio Corporation Information
Table 158. Hualan Bio Description and Major Businesses
Table 159. Hualan Bio Plasma Fractionation and Blood Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 160. Hualan Bio Plasma Fractionation and Blood Product Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Hualan Bio Recent Developments
Table 162. Key Raw Materials Lists
Table 163. Raw Materials Key Suppliers Lists
Table 164. Plasma Fractionation and Blood Product Distributors List
Table 165. Plasma Fractionation and Blood Product Customers List
Table 166. Plasma Fractionation and Blood Product Market Trends
Table 167. Plasma Fractionation and Blood Product Market Drivers
Table 168. Plasma Fractionation and Blood Product Market Challenges
Table 169. Plasma Fractionation and Blood Product Market Restraints
Table 170. Research Programs/Design for This Report
Table 171. Key Data Information from Secondary Sources
Table 172. Key Data Information from Primary Sources
List of Figures
Figure 1. Plasma Fractionation and Blood Product Product Picture
Figure 3. Global Plasma Fractionation and Blood Product Market Share by Type in 2021 & 2028
Figure 3. Coagulation Factor Product Picture
Figure 4. Immune Globulin Product Picture
Figure 5. Albumin Product Picture
Figure 6. Other Product Picture
Figure 7. Global Plasma Fractionation and Blood Product Market Share by Application in 2021 & 2028
Figure 8. Immunology
Figure 9. Hematology
Figure 10. Other
Figure 11. Plasma Fractionation and Blood Product Report Years Considered
Figure 12. Global Plasma Fractionation and Blood Product Sales 2017-2028 (K Units)
Figure 13. Global Plasma Fractionation and Blood Product Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Plasma Fractionation and Blood Product Revenue 2017-2028 (US$ Million)
Figure 15. Global Plasma Fractionation and Blood Product Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 16. Global Plasma Fractionation and Blood Product Sales Market Share by Region (2017-2022)
Figure 17. Global Plasma Fractionation and Blood Product Sales Market Share by Region (2023-2028)
Figure 18. North America Plasma Fractionation and Blood Product Sales YoY (2017-2028) & (K Units)
Figure 19. North America Plasma Fractionation and Blood Product Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Europe Plasma Fractionation and Blood Product Sales YoY (2017-2028) & (K Units)
Figure 21. Europe Plasma Fractionation and Blood Product Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Asia-Pacific Plasma Fractionation and Blood Product Sales YoY (2017-2028) & (K Units)
Figure 23. Asia-Pacific Plasma Fractionation and Blood Product Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Latin America Plasma Fractionation and Blood Product Sales YoY (2017-2028) & (K Units)
Figure 25. Latin America Plasma Fractionation and Blood Product Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Middle East & Africa Plasma Fractionation and Blood Product Sales YoY (2017-2028) & (K Units)
Figure 27. Middle East & Africa Plasma Fractionation and Blood Product Revenue YoY (2017-2028) & (US$ Million)
Figure 28. The Plasma Fractionation and Blood Product Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 29. The Top 5 and 10 Largest Manufacturers of Plasma Fractionation and Blood Product in the World: Market Share by Plasma Fractionation and Blood Product Revenue in 2021
Figure 30. Global Plasma Fractionation and Blood Product Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 31. Global Plasma Fractionation and Blood Product Sales Market Share by Type (2017-2028)
Figure 32. Global Plasma Fractionation and Blood Product Revenue Market Share by Type (2017-2028)
Figure 33. Global Plasma Fractionation and Blood Product Sales Market Share by Application (2017-2028)
Figure 34. Global Plasma Fractionation and Blood Product Revenue Market Share by Application (2017-2028)
Figure 35. North America Plasma Fractionation and Blood Product Sales Market Share by Type (2017-2028)
Figure 36. North America Plasma Fractionation and Blood Product Revenue Market Share by Type (2017-2028)
Figure 37. North America Plasma Fractionation and Blood Product Sales Market Share by Application (2017-2028)
Figure 38. North America Plasma Fractionation and Blood Product Revenue Market Share by Application (2017-2028)
Figure 39. North America Plasma Fractionation and Blood Product Sales Share by Country (2017-2028)
Figure 40. North America Plasma Fractionation and Blood Product Revenue Share by Country (2017-2028)
Figure 41. U.S. Plasma Fractionation and Blood Product Revenue (2017-2028) & (US$ Million)
Figure 42. Canada Plasma Fractionation and Blood Product Revenue (2017-2028) & (US$ Million)
Figure 43. Europe Plasma Fractionation and Blood Product Sales Market Share by Type (2017-2028)
Figure 44. Europe Plasma Fractionation and Blood Product Revenue Market Share by Type (2017-2028)
Figure 45. Europe Plasma Fractionation and Blood Product Sales Market Share by Application (2017-2028)
Figure 46. Europe Plasma Fractionation and Blood Product Revenue Market Share by Application (2017-2028)
Figure 47. Europe Plasma Fractionation and Blood Product Sales Share by Country (2017-2028)
Figure 48. Europe Plasma Fractionation and Blood Product Revenue Share by Country (2017-2028)
Figure 49. Germany Plasma Fractionation and Blood Product Revenue (2017-2028) & (US$ Million)
Figure 50. France Plasma Fractionation and Blood Product Revenue (2017-2028) & (US$ Million)
Figure 51. U.K. Plasma Fractionation and Blood Product Revenue (2017-2028) & (US$ Million)
Figure 52. Italy Plasma Fractionation and Blood Product Revenue (2017-2028) & (US$ Million)
Figure 53. Russia Plasma Fractionation and Blood Product Revenue (2017-2028) & (US$ Million)
Figure 54. Asia Pacific Plasma Fractionation and Blood Product Sales Market Share by Type (2017-2028)
Figure 55. Asia Pacific Plasma Fractionation and Blood Product Revenue Market Share by Type (2017-2028)
Figure 56. Asia Pacific Plasma Fractionation and Blood Product Sales Market Share by Application (2017-2028)
Figure 57. Asia Pacific Plasma Fractionation and Blood Product Revenue Market Share by Application (2017-2028)
Figure 58. Asia Pacific Plasma Fractionation and Blood Product Sales Share by Region (2017-2028)
Figure 59. Asia Pacific Plasma Fractionation and Blood Product Revenue Share by Region (2017-2028)
Figure 60. China Plasma Fractionation and Blood Product Revenue (2017-2028) & (US$ Million)
Figure 61. Japan Plasma Fractionation and Blood Product Revenue (2017-2028) & (US$ Million)
Figure 62. South Korea Plasma Fractionation and Blood Product Revenue (2017-2028) & (US$ Million)
Figure 63. India Plasma Fractionation and Blood Product Revenue (2017-2028) & (US$ Million)
Figure 64. Australia Plasma Fractionation and Blood Product Revenue (2017-2028) & (US$ Million)
Figure 65. Taiwan Plasma Fractionation and Blood Product Revenue (2017-2028) & (US$ Million)
Figure 66. Indonesia Plasma Fractionation and Blood Product Revenue (2017-2028) & (US$ Million)
Figure 67. Thailand Plasma Fractionation and Blood Product Revenue (2017-2028) & (US$ Million)
Figure 68. Malaysia Plasma Fractionation and Blood Product Revenue (2017-2028) & (US$ Million)
Figure 69. Philippines Plasma Fractionation and Blood Product Revenue (2017-2028) & (US$ Million)
Figure 70. Latin America Plasma Fractionation and Blood Product Sales Market Share by Type (2017-2028)
Figure 71. Latin America Plasma Fractionation and Blood Product Revenue Market Share by Type (2017-2028)
Figure 72. Latin America Plasma Fractionation and Blood Product Sales Market Share by Application (2017-2028)
Figure 73. Latin America Plasma Fractionation and Blood Product Revenue Market Share by Application (2017-2028)
Figure 74. Latin America Plasma Fractionation and Blood Product Sales Share by Country (2017-2028)
Figure 75. Latin America Plasma Fractionation and Blood Product Revenue Share by Country (2017-2028)
Figure 76. Mexico Plasma Fractionation and Blood Product Revenue (2017-2028) & (US$ Million)
Figure 77. Brazil Plasma Fractionation and Blood Product Revenue (2017-2028) & (US$ Million)
Figure 78. Argentina Plasma Fractionation and Blood Product Revenue (2017-2028) & (US$ Million)
Figure 79. Middle East and Africa Plasma Fractionation and Blood Product Sales Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Plasma Fractionation and Blood Product Revenue Market Share by Type (2017-2028)
Figure 81. Middle East and Africa Plasma Fractionation and Blood Product Sales Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Plasma Fractionation and Blood Product Revenue Market Share by Application (2017-2028)
Figure 83. Middle East and Africa Plasma Fractionation and Blood Product Sales Share by Country (2017-2028)
Figure 84. Middle East and Africa Plasma Fractionation and Blood Product Revenue Share by Country (2017-2028)
Figure 85. Turkey Plasma Fractionation and Blood Product Revenue (2017-2028) & (US$ Million)
Figure 86. Saudi Arabia Plasma Fractionation and Blood Product Revenue (2017-2028) & (US$ Million)
Figure 87. U.A.E Plasma Fractionation and Blood Product Revenue (2017-2028) & (US$ Million)
Figure 88. Plasma Fractionation and Blood Product Value Chain
Figure 89. Plasma Fractionation and Blood Product Production Process
Figure 90. Channels of Distribution
Figure 91. Distributors Profiles
Figure 92. Bottom-up and Top-down Approaches for This Report
Figure 93. Data Triangulation
Figure 94. Key Executives Interviewed
